{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:46:52Z","timestamp":1772196412679,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.03.036","type":"journal-article","created":{"date-parts":[[2009,4,6]],"date-time":"2009-04-06T08:23:57Z","timestamp":1239006237000},"page":"3026-3034","source":"Crossref","is-referenced-by-count":32,"title":["A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice"],"prefix":"10.1016","volume":"27","author":[{"given":"Shen-An","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Wilk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian L.","family":"Kruzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey K.","family":"Actor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2009.03.036_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.1999.0206","article-title":"Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree","volume":"79","author":"Oettinger","year":"1999","journal-title":"Tuber Lung Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.03.036_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1473-3099(02)00182-2","article-title":"BCG\u2014different strains, different vaccines?","volume":"2","author":"Behr","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2009.03.036_bib3","article-title":"Global epidemiology of tuberculosis","volume":"26","author":"Maher","year":"2005","journal-title":"Clin Chest Med"},{"issue":"July (1 Pt 1)","key":"10.1016\/j.vaccine.2009.03.036_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.036_bib5","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"March 18 (17\u201318)","key":"10.1016\/j.vaccine.2009.03.036_bib6","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.vaccine.2005.01.060","article-title":"Real world TB vaccines: clinical trials in TB-endemic regions","volume":"23","author":"Doherty","year":"2005","journal-title":"Vaccine"},{"issue":"December (50)","key":"10.1016\/j.vaccine.2009.03.036_bib7","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1016\/j.vaccine.2005.07.045","article-title":"A review of vaccine research and development: tuberculosis","volume":"23","author":"Girard","year":"2005","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.03.036_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1054\/tube.2000.0265","article-title":"A coordinated strategy for evaluating new vaccines for human and animal tuberculosis","volume":"81","author":"McMurray","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"issue":"Mar (473)","key":"10.1016\/j.vaccine.2009.03.036_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1198\/016214505000000970","article-title":"Causal vaccine effects on binary postinfection outcomes","volume":"101","author":"Hudgens","year":"2006","journal-title":"J Am Stat Assoc"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.03.036_bib10","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1517\/14712598.7.11.1665","article-title":"How a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis","volume":"7","author":"Locht","year":"2007","journal-title":"Expert Opin Biol Ther"},{"issue":"January\u2013March (1\u20132)","key":"10.1016\/j.vaccine.2009.03.036_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2004.10.002","article-title":"TB vaccines for the World","volume":"85","author":"Glyn Hewinson","year":"2005","journal-title":"Tuberculosis (Edinb)"},{"issue":"December (25)","key":"10.1016\/j.vaccine.2009.03.036_bib12","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.03.036_bib13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.it.2005.09.012","article-title":"Recent findings in immunology give tuberculosis vaccines a new boost","volume":"26","author":"Kaufmann","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2009.03.036_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.03.036_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2003.08.010","article-title":"Immunology of tuberculosis and implications in vaccine development","volume":"84","author":"Flynn","year":"2004","journal-title":"Tuberculosis (Edinb)"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2009.03.036_bib16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.vaccine.2005.01.069","article-title":"Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?","volume":"23","author":"Rook","year":"2005","journal-title":"Vaccine"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2009.03.036_bib17","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2007.01.112","article-title":"Current status of TB vaccines","volume":"25","author":"Gupta","year":"2007","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2009.03.036_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","article-title":"IL-4 in tuberculosis: implications for vaccine design","volume":"25","author":"Rook","year":"2004","journal-title":"Trends Immunol"},{"issue":"June (Suppl. 3)","key":"10.1016\/j.vaccine.2009.03.036_bib19","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1086\/313883","article-title":"Improving vaccine performance with adjuvants","volume":"30","author":"Vogel","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.03.036_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/intimm\/dxg091","article-title":"Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis","volume":"15","author":"Dascher","year":"2003","journal-title":"Int Immunol"},{"issue":"May (5\u20136)","key":"10.1016\/j.vaccine.2009.03.036_bib21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0020-7519(03)00061-4","article-title":"Recent progress in the development and testing of vaccines against human tuberculosis","volume":"33","author":"McMurray","year":"2003","journal-title":"Int J Parasitol"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2009.03.036_bib22","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.vaccine.2003.10.016","article-title":"Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis","volume":"22","author":"Haile","year":"2004","journal-title":"Vaccine"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2009.03.036_bib23","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2003.05.002","article-title":"A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis","volume":"22","author":"Chambers","year":"2004","journal-title":"Vaccine"},{"issue":"September (37\u201338)","key":"10.1016\/j.vaccine.2009.03.036_bib24","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1016\/j.vaccine.2007.07.005","article-title":"Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis","volume":"25","author":"Hwang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.03.036_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-0-387-74087-4_6","article-title":"Lactoferrin structure and functions","volume":"606","author":"Legrand","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2009.03.036_bib26","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00018-005-5368-9","article-title":"Molecular structure, binding properties and dynamics of lactoferrin","volume":"62","author":"Baker","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2009.03.036_bib27","first-page":"268","article-title":"Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: effect of lactoferrin","volume":"61","author":"Chodaczek","year":"2007","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"10.1016\/j.vaccine.2009.03.036_bib28","first-page":"261","article-title":"Lactoferrin in health and disease","volume":"61","author":"Kruzel","year":"2007","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"1","key":"10.1016\/j.vaccine.2009.03.036_bib29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biochi.2008.04.008","article-title":"Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages","volume":"91","author":"Hwang","year":"2009","journal-title":"Biochimie"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.03.036_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00430-007-0041-6","article-title":"Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes","volume":"196","author":"Hwang","year":"2007","journal-title":"Med Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.036_bib31","first-page":"399","article-title":"Lactoferrin and immunologic dissonance: clinical implications","volume":"50","author":"Kruzel","year":"2002","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"October (2)","key":"10.1016\/j.vaccine.2009.03.036_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2567.2006.02417.x","article-title":"Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma","volume":"119","author":"Kruzel","year":"2006","journal-title":"Immunology"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2009.03.036_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1567-5769(01)00189-8","article-title":"Lactoferrin immunomodulation of DTH response in mice","volume":"2","author":"Actor","year":"2002","journal-title":"Int Immunopharmacol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.036_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.intimp.2004.11.006","article-title":"Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis","volume":"5","author":"Hwang","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2009.03.036_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-4757-9068-9_41","article-title":"Lactoferrin. Its role in maturation and function of cells of the immune system and protection against shock in mice","volume":"443","author":"Zimecki","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2009.03.036_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-2478(00)00260-1","article-title":"Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice","volume":"74","author":"Zimecki","year":"2000","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2009.03.036_bib37","first-page":"277","article-title":"Lactoferrin modulation of antigen-presenting-cell response to BCG infection","volume":"61","author":"Wilk","year":"2007","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"6","key":"10.1016\/j.vaccine.2009.03.036_bib38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10719-008-9123-y","article-title":"Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response","volume":"25","author":"Choi","year":"2008","journal-title":"Glycoconj J"},{"issue":"3","key":"10.1016\/j.vaccine.2009.03.036_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.03.036_bib40","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1128\/IAI.72.12.7084-7095.2004","article-title":"A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential","volume":"72","author":"Copenhaver","year":"2004","journal-title":"Infect Immun"},{"issue":"October (1)","key":"10.1016\/j.vaccine.2009.03.036_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vetmic.2006.04.007","article-title":"New understanding of immunological mechanisms","volume":"117","author":"Saalmuller","year":"2006","journal-title":"Vet Microbiol"},{"issue":"April (4 Suppl.)","key":"10.1016\/j.vaccine.2009.03.036_bib42","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/nm1212","article-title":"T cell vaccines for microbial infections","volume":"11","author":"Robinson","year":"2005","journal-title":"Nat Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.03.036_bib43","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI34614","article-title":"Confronting the scientific obstacles to global control of tuberculosis","volume":"118","author":"Young","year":"2008","journal-title":"J Clin Invest"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.03.036_bib44","first-page":"324","article-title":"The guinea pig as a model of infectious diseases","volume":"58","author":"Padilla-Carlin","year":"2008","journal-title":"Comp Med"},{"issue":"March (2\u20133)","key":"10.1016\/j.vaccine.2009.03.036_bib45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cimid.2007.07.003","article-title":"Bovine TB and the development of new vaccines","volume":"31","author":"Hope","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.03.036_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biochi.2008.04.008","article-title":"Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages","volume":"91","author":"Hwang","year":"2009","journal-title":"Biochimie"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.036_bib47","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/CVI.00408-07","article-title":"Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice","volume":"15","author":"Beamer","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.03.036_bib48","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/IAI.68.6.3322-3326.2000","article-title":"Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection","volume":"68","author":"Saunders","year":"2000","journal-title":"Infect Immun"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2009.03.036_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/156652407780598557","article-title":"Th2 cytokines in susceptibility to tuberculosis","volume":"7","author":"Rook","year":"2007","journal-title":"Curr Mol Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.03.036_bib50","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.03.036_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-842X(00)01949-1","article-title":"Tuberculosis vaccine development: recent progress","volume":"9","author":"Orme","year":"2001","journal-title":"Trends Microbiol"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2009.03.036_bib52","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s00018-005-5370-2","article-title":"Lactoferrin: a modulator of immune and inflammatory responses","volume":"62","author":"Legrand","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2009.03.036_bib53","first-page":"283","article-title":"Immunoregulatory function of lactoferrin in immunosuppressed and autoimmune animals","volume":"61","author":"Zimecki","year":"2007","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2009.03.036_bib54","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1016-8478(23)13480-7","article-title":"Structure of the human lactoferrin gene and its chromosomal localization","volume":"8","author":"Kim","year":"1998","journal-title":"Mol Cells"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2009.03.036_bib55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1432-1033.2003.03965.x","article-title":"The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis","volume":"271","author":"van Veen","year":"2004","journal-title":"Eur J Biochem"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.03.036_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11248-005-3233-0","article-title":"The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin","volume":"14","author":"Thomassen","year":"2005","journal-title":"Transgenic Res"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2009.03.036_bib57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11248-004-8120-6","article-title":"Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain","volume":"14","author":"Nandi","year":"2005","journal-title":"Transgenic Res"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.03.036_bib58","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/elps.1150171218","article-title":"Comparison of heparin-binding to lactoferrin from human milk and from human granulocytes by means of affinity capillary electrophoresis","volume":"17","author":"Heegaard","year":"1996","journal-title":"Electrophoresis"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2009.03.036_bib59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/bj2290353","article-title":"Comparison of human lactoferrins from milk and neutrophilic leucocytes. Relative molecular mass, isoelectric point, iron-binding properties and uptake by the liver","volume":"229","author":"Moguilevsky","year":"1985","journal-title":"Biochem J"},{"issue":"June","key":"10.1016\/j.vaccine.2009.03.036_bib60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.1998.tb01185.x","article-title":"The C-type lectin superfamily in the immune system","volume":"163","author":"Weis","year":"1998","journal-title":"Immunol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09004538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T11:09:53Z","timestamp":1710241793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09004538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":60,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09004538"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}